| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in financing activities | -10,367 | -8,726 |
| Effect of exchange rate changes on cash | 705 | 827 |
| Net increase/(decrease) in cash and cash equivalents | 1,291 | -797 |
| Cash and cash equivalents at beginning of period | 82,976 | - |
| Cash and cash equivalents at end of period | 84,267 | - |
UTAH MEDICAL PRODUCTS INC (UTMD)
UTAH MEDICAL PRODUCTS INC (UTMD)